Immune Privilege: The Microbiome and Uveitis

Immune privilege (IP), a term introduced to explain the unpredicted acceptance of allogeneic grafts by the eye and the brain, is considered a unique property of these tissues. However, immune responses are modified by the tissue in which they occur, most of which possess IP to some degree. The eye t...

Full description

Bibliographic Details
Main Authors: Christine Mölzer, Jarmila Heissigerova, Heather M. Wilson, Lucia Kuffova, John V. Forrester
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.608377/full
id doaj-7ca7cc0d4b914a1fb6c365245a9a75e7
record_format Article
spelling doaj-7ca7cc0d4b914a1fb6c365245a9a75e72021-01-25T07:05:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-01-011110.3389/fimmu.2020.608377608377Immune Privilege: The Microbiome and UveitisChristine Mölzer0Jarmila Heissigerova1Heather M. Wilson2Lucia Kuffova3Lucia Kuffova4John V. Forrester5Institute of Medical Sciences, University of Aberdeen, Aberdeen, United KingdomDepartment of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, CzechiaInstitute of Medical Sciences, University of Aberdeen, Aberdeen, United KingdomInstitute of Medical Sciences, University of Aberdeen, Aberdeen, United KingdomEye Clinic, Aberdeen Royal Infirmary, Aberdeen, United KingdomInstitute of Medical Sciences, University of Aberdeen, Aberdeen, United KingdomImmune privilege (IP), a term introduced to explain the unpredicted acceptance of allogeneic grafts by the eye and the brain, is considered a unique property of these tissues. However, immune responses are modified by the tissue in which they occur, most of which possess IP to some degree. The eye therefore displays a spectrum of IP because it comprises several tissues. IP as originally conceived can only apply to the retina as it contains few tissue-resident bone-marrow derived myeloid cells and is immunologically shielded by a sophisticated barrier – an inner vascular and an outer epithelial barrier at the retinal pigment epithelium. The vascular barrier comprises the vascular endothelium and the glia limitans. Immune cells do not cross the blood-retinal barrier (BRB) despite two-way transport of interstitial fluid, governed by tissue oncotic pressure. The BRB, and the blood-brain barrier (BBB) mature in the neonatal period under signals from the expanding microbiome and by 18 months are fully established. However, the adult eye is susceptible to intraocular inflammation (uveitis; frequency ~200/100,000 population). Uveitis involving the retinal parenchyma (posterior uveitis, PU) breaches IP, while IP is essentially irrelevant in inflammation involving the ocular chambers, uveal tract and ocular coats (anterior/intermediate uveitis/sclerouveitis, AU). Infections cause ~50% cases of AU and PU but infection may also underlie the pathogenesis of immune-mediated “non-infectious” uveitis. Dysbiosis accompanies the commonest form, HLA-B27–associated AU, while latent infections underlie BRB breakdown in PU. This review considers the pathogenesis of uveitis in the context of IP, infection, environment, and the microbiome.https://www.frontiersin.org/articles/10.3389/fimmu.2020.608377/fullT regulatory cellsfolateprobioticsblood retinal barrieradjuvant effectcommensals
collection DOAJ
language English
format Article
sources DOAJ
author Christine Mölzer
Jarmila Heissigerova
Heather M. Wilson
Lucia Kuffova
Lucia Kuffova
John V. Forrester
spellingShingle Christine Mölzer
Jarmila Heissigerova
Heather M. Wilson
Lucia Kuffova
Lucia Kuffova
John V. Forrester
Immune Privilege: The Microbiome and Uveitis
Frontiers in Immunology
T regulatory cells
folate
probiotics
blood retinal barrier
adjuvant effect
commensals
author_facet Christine Mölzer
Jarmila Heissigerova
Heather M. Wilson
Lucia Kuffova
Lucia Kuffova
John V. Forrester
author_sort Christine Mölzer
title Immune Privilege: The Microbiome and Uveitis
title_short Immune Privilege: The Microbiome and Uveitis
title_full Immune Privilege: The Microbiome and Uveitis
title_fullStr Immune Privilege: The Microbiome and Uveitis
title_full_unstemmed Immune Privilege: The Microbiome and Uveitis
title_sort immune privilege: the microbiome and uveitis
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-01-01
description Immune privilege (IP), a term introduced to explain the unpredicted acceptance of allogeneic grafts by the eye and the brain, is considered a unique property of these tissues. However, immune responses are modified by the tissue in which they occur, most of which possess IP to some degree. The eye therefore displays a spectrum of IP because it comprises several tissues. IP as originally conceived can only apply to the retina as it contains few tissue-resident bone-marrow derived myeloid cells and is immunologically shielded by a sophisticated barrier – an inner vascular and an outer epithelial barrier at the retinal pigment epithelium. The vascular barrier comprises the vascular endothelium and the glia limitans. Immune cells do not cross the blood-retinal barrier (BRB) despite two-way transport of interstitial fluid, governed by tissue oncotic pressure. The BRB, and the blood-brain barrier (BBB) mature in the neonatal period under signals from the expanding microbiome and by 18 months are fully established. However, the adult eye is susceptible to intraocular inflammation (uveitis; frequency ~200/100,000 population). Uveitis involving the retinal parenchyma (posterior uveitis, PU) breaches IP, while IP is essentially irrelevant in inflammation involving the ocular chambers, uveal tract and ocular coats (anterior/intermediate uveitis/sclerouveitis, AU). Infections cause ~50% cases of AU and PU but infection may also underlie the pathogenesis of immune-mediated “non-infectious” uveitis. Dysbiosis accompanies the commonest form, HLA-B27–associated AU, while latent infections underlie BRB breakdown in PU. This review considers the pathogenesis of uveitis in the context of IP, infection, environment, and the microbiome.
topic T regulatory cells
folate
probiotics
blood retinal barrier
adjuvant effect
commensals
url https://www.frontiersin.org/articles/10.3389/fimmu.2020.608377/full
work_keys_str_mv AT christinemolzer immuneprivilegethemicrobiomeanduveitis
AT jarmilaheissigerova immuneprivilegethemicrobiomeanduveitis
AT heathermwilson immuneprivilegethemicrobiomeanduveitis
AT luciakuffova immuneprivilegethemicrobiomeanduveitis
AT luciakuffova immuneprivilegethemicrobiomeanduveitis
AT johnvforrester immuneprivilegethemicrobiomeanduveitis
_version_ 1724324603458748416